Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Express Scripts
Johnson and Johnson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,162,362

« Back to Dashboard

Summary for Patent: 5,162,362

Title: Octahydroindole-2-carboxylic acids
Abstract:What are disclosed are aminoacid compounds of the formula ##STR1## wherein n is 0 or 1, and salts thereof, said compounds and salts having hypotensive properties; methods for making the compounds; pharmaceutical compositions containing the compounds or salts; and use of the compounds and salts for treating hypertension.
Inventor(s): Geiger; Rolf (Frankfurt am Main, DE), Teetz; Volker (Hofheim am Taunus, DE), Urbach; Hansjorg (Kronberg/Taunus, DE), Scholkens; Bernward (Kelkheim, DE), Henning; Rainer (Giessen, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:06/565,887
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,162,362

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3032709Aug 30, 1980
Germany3118191May 08, 1981

International Patent Family for Patent: 5,162,362

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland90069► Subscribe
Czechoslovakia9104094► Subscribe
Germany3032709► Subscribe
Germany3118191► Subscribe
Germany3177130► Subscribe
Germany3177311► Subscribe
Denmark383581► Subscribe
Denmark169382► Subscribe
European Patent Office0046953► Subscribe
European Patent Office0278530► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus